BPI Recombinant Antibody, PE-Cy5 Conjugated
Product Specifications
Background
The cytotoxic action of BPI is limited to many species of Gram-negative bacteria; this specificity may be explained by a strong affinity of the very basic N-terminal half for the negatively charged lipopolysaccharides that are unique to the Gram-negative bacterial outer envelope. Has antibacterial activity against the Gram-negative bacterium P.aeruginosa, this activity is inhibited by LPS from P.aeruginosa.
Synonyms
RBPI; BPIFD1; CAP 57; BPI; Bactericidal permeability-increasing protein.
Gene ID
671
Swiss Prot
P17213
Cellular Locus
Cytoplasm, Secreted, Cell membrane
Host
Rabbit
Cross Reactivity
Human
Target
BPI
Clonality
Recombinant
Isotype
IgG
Conjugation
PE-Cy5
Source
KLH conjugated synthetic peptide derived from human BPI
Applications
WB, Flow-Cyt
Purification
Purified by Protein A.
Excitation Emission
488nm/670nm
Concentration
Lot dependent
Dilution
WB (1:300-5000), Flow-Cyt (1ug/Test)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
671
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1445342-01 0.02 mg (E-Coli)
Recombinant Vibrio cholerae serotype O1 Autoinducer 2-binding periplasmic protein luxP (luxP)
Ask
View Details MBS1445342-02 0.02 mg (Yeast)
Recombinant Vibrio cholerae serotype O1 Autoinducer 2-binding periplasmic protein luxP (luxP)
Ask
View Details